Research Article
Study on the Evaluation of Lung Cancer Patients from the Three Aspects of Emotion
Table 3
EORTC-QLQ-LC13 evaluation of the QoL of patients with lung cancer (
).
| QLQ-LC13 | EORTC phase III-IV reference value (n = 1313) | Pre-chemotherapy score (n = 219) | T value | Post-chemotherapy score (n = 212) | F value |
| Cough | 38.4 ± 22.3 | 35.47 ± 23.14 | −1.78 | 32.76 ± 23.54 | 0.92 | Hemoptysis | 7.7 ± 17 | 12.64 ± 13.54 | 3.70 | 14.33 ± 21.27 | 0.39 | Difficulty breathing | 21.5 ± 24.6 | 25.34 ± 21.37 | −4.14 | 28.06 ± 25.08 | 1.26 | Mouth pain | 5.1 ± 14.9 | 11.00 ± 18.24 | 4.45 | 13.24 ± 22.39 | 1.69 | Hard to swallow | 6.8 ± 17.8 | 10.02 ± 20.35 | 2.20 | 15.33 ± 26.09 | 4.89 | Peripheral neuralgia | 8.9 ± 19.36 | 15.60 ± 23.11 | 4.10 | 21.00 ± 28.17 | 2.47 | Hair loss | 5.2 ± 19.17 | 1.15 ± 8.38 | −6.89 | 37.50 ± 32.90 | 115.74 | Chest pain | 20.8 ± 26.6 | 25.94 ± 27.35 | 2.69 | 29.00 ± 30.50 | 0.72 | Arm shoulder pain | 22.4 ± 27.52 | 16.42 ± 24.42 | −3.51 | 18.83 ± 27.27 | 1.76 | Other pain | 23.8 ± 13.4 | 18.06 ± 15.19 | −3.45 | 20.67 ± 17.81 | 1.66 |
|
|